Top compounds associated with response to MYBPH


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.091 0.01
mRNA FQI-2 CTRPv2 pan-cancer AAC -0.08 0.01
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.01
mRNA KIN001-102 GDSC1000 pan-cancer AAC 0.074 0.01
mRNA PF-562271 GDSC1000 pan-cancer AAC 0.083 0.01
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC 0.076 0.01
mRNA BX-912 GDSC1000 pan-cancer AAC 0.072 0.01
mRNA BRD-A02303741 CTRPv2 pan-cancer AAC 0.091 0.01
mRNA ATRA FIMM pan-cancer AAC 0.48 0.01
mRNA AZD6482 CTRPv2 pan-cancer AAC 0.086 0.02
Download CSV